Clinical Trials

454 enrolled 23 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT01349959 2025-04-27

Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer

58 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00096434 2024-03-07

Sorafenib in Treating Patients With Metastatic Breast Cancer

23 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT03394027 2022-08-23

ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

30 enrolled 15 charts

BreastGynecologic

Neoplasm Metastasis, Endometrial Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00118157 2017-12-04

Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

19 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01151449 2017-04-11

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer

Phase 2 Terminated

6 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00244881 2015-12-07

A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)

26 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00132002 2015-03-19

Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer

Phase 2 Terminated

14 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00068588 2014-10-31

GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer

24 enrolled 4 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00077376 2014-05-21

Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer

61 enrolled 12 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00119262 2014-05-15

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

226 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00559507 2014-04-30

Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery

12 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00003253 2013-12-19

Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

Phase 2 Unknown

100 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00022204 2013-11-06

Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer

Breast Neoplasms, Lymphedema, Breast Neoplasms, Male

NCT00006228 2013-10-08

Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

NCT00020176 2013-06-20

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

NCT00045097 2013-06-20

Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

NCT00098605 2013-06-06

Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases

BreastCNS

Brain Neoplasms, Breast Neoplasms, Breast Neoplasms, Male

NCT00044993 2013-05-30

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

NCT00003796 2013-02-11

Irofulven in Treating Patients With Metastatic Breast Cancer

32 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00005817 2013-02-01

Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer

42 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00024154 2013-01-24

Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer

132 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00098397 2013-01-24

FR901228 in Treating Patients With Metastatic Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

NCT00045188 2013-01-23

Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer

35 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00017394 2013-01-17

Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer

56 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00095888 2013-01-16

3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer

Phase 2 Terminated

68 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00019812 2012-03-23

Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2

55 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00301899 2012-03-08

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab